Cell-Penetrant, Nanomolar O-GlcNAcase Inhibitors Selective against Lysosomal Hexosaminidases
2010

New Inhibitors for O-GlcNAcase

publication Evidence: high

Author Information

Author(s): Helge C. Dorfmueller, Vladimir S. Borodkin, Marianne Schimpl, Xiaowei Zheng, Robert Kime, Kevin D. Read, Daan M.F. van Aalten

Primary Institution: University of Dundee

Hypothesis

Can we develop selective inhibitors for O-GlcNAcase that do not affect lysosomal hexosaminidases?

Conclusion

The new GlcNAcstatin inhibitors are highly selective for O-GlcNAcase and can penetrate live cells to induce hyper-O-GlcNAcylation.

Supporting Evidence

  • The new GlcNAcstatins show up to 900,000-fold selectivity over lysosomal hexosaminidases.
  • These inhibitors can penetrate live cells and induce hyper-O-GlcNAcylation.
  • The EC50 values for the inhibitors are in the low nanomolar range.

Takeaway

Scientists created new drugs that can help study how a sugar modification affects cell behavior without messing with similar enzymes.

Methodology

The study involved designing and testing new inhibitors in cell-based assays and using X-ray crystallography to analyze their selectivity.

Limitations

The study does not address long-term effects of these inhibitors on cellular processes.

Digital Object Identifier (DOI)

10.1016/j.chembiol.2010.09.014

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication